Estimates of health utility scores in chronic kidney disease

被引:3
|
作者
Sekercioglu, Nigar [1 ]
Curtis, Bryan [1 ,2 ]
Murphy, Sean [1 ,2 ]
Blackhouse, Gord [3 ]
Barrett, Brendan [1 ,2 ]
机构
[1] Mem Univ, Fac Med, Dept Clin Epidemiol, 300 Prince Philip Dr, St John, NF, Canada
[2] Mem Univ, Fac Med, Div Nephrol, 300 Prince Philip Dr, St John, NF, Canada
[3] McMaster Univ, Programs Assessment Technol Hlth, 3 Charlton Ave E,2nd Floor, Hamilton, ON L8N 1Y3, Canada
关键词
Chronic kidney disease; Discrete choice experiment; Parametric inference; Cost-utility analysis; QUALITY-OF-LIFE; PREFERENCE-BASED MEASURE; SF-36; DEPRESSION;
D O I
10.1007/s11255-017-1664-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Coverage decisions in publicly funded healthcare systems require a formal, systematic and transparent assessment process for policies related to distribution of resources. The process is complex and employs multiple types of information, such as clinical effectiveness, costs and health utility scores which are used to produce quality-adjusted life years. The purpose of this study was to create health utility scores for CKD patients within the Canadian population. This is a cross-sectional study of CKD patients. We administered the Short-Form 36 Quality of Life Questions to all participants and employed the Short-Form 6 Dimension index to create health utility scores which were created using a set of parametric preference weights, nonparametric preference weights and ordinal health state valuation techniques obtained from a sample of the general population. Utility values in the dialysis group were lower than in the non-dialysis group. There was a significant relationship between age and health utility scores: As age increases, health utility scores decrease. Diabetes was associated with lower health utility scores in dialysis patients, whereas other covariates did not reach levels of statistical significance in our stepwise regression models. The parametric Bayesian model and standard gamble approach yielded the same results, while the correlation between the nonparametric and parametric methods was above 0.9. Health utility scores were low relative to the general population norm in our study cohort. Longitudinal assessment of CKD patients to capture possible fluctuations in health utility scores may add useful information.
引用
收藏
页码:2043 / 2049
页数:7
相关论文
共 50 条
  • [21] CLINICAL UTILITY OF BIOMARKERS IN CHRONIC KIDNEY DISEASE AND CHRONIC HEART FAILURE
    Zachariah, Donah
    Olechowski, Bartosz
    Kalra, Paul R.
    JOURNAL OF RENAL CARE, 2013, 39 (03) : 128 - 139
  • [22] Health literacy and chronic kidney disease
    Costa-Requena, Gema
    Moreso, Francesc
    Carmen Cantarell, M.
    Seron, Daniel
    NEFROLOGIA, 2017, 37 (02): : 115 - 117
  • [23] CHRONIC KIDNEY DISEASE Health burden of kidney disease recognized by UN
    Feehally, John
    NATURE REVIEWS NEPHROLOGY, 2012, 8 (01) : 12 - 13
  • [24] Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia
    Kruger, Eliza
    Aggio, Daniel
    de Freitas, Hayley
    Lloyd, Andrew
    PHARMACOECONOMICS-OPEN, 2023, 7 (04) : 627 - 638
  • [25] Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia
    Eliza Kruger
    Daniel Aggio
    Hayley de Freitas
    Andrew Lloyd
    PharmacoEconomics - Open, 2023, 7 : 627 - 638
  • [26] Potential Biases in Post-Stroke Health Utility Estimates by Modified Rankin Scale Scores
    Yoshioka, Takashi
    VALUE IN HEALTH, 2025, 28 (02) : 319 - 320
  • [27] Utility of mammography for chronic kidney disease patients undergoing kidney transplant evaluation
    Stoecker, Jordan B.
    Cote, Devan R.
    Augustine, Joshua J.
    Sarabu, Nagaraju
    Schulak, James A.
    Sanchez, Edmund Q.
    Humphreville, Vanessa R.
    Ammori, John B.
    Woodside, Kenneth J.
    CLINICAL TRANSPLANTATION, 2016, 30 (04) : 445 - 451
  • [28] The global burden of chronic kidney disease: Estimates, variability and pitfalls
    Glassock R.J.
    Warnock D.G.
    Delanaye P.
    Nature Reviews Nephrology, 2017, 13 (2) : 104 - 114
  • [29] The global burden of chronic kidney disease: estimates, variability and pitfalls
    Glassock, Richard J.
    Warnock, David G.
    Delanaye, Pierre
    NATURE REVIEWS NEPHROLOGY, 2017, 13 (02) : 104 - 114
  • [30] The global burden of chronic kidney disease: How valid are the estimates?
    Glassock, Richard J.
    Winearls, Christopher
    NEPHRON CLINICAL PRACTICE, 2008, 110 (01): : C39 - C46